FDA Investigator Jeanne M Morris

Jeanne M Morris has inspections in 4 countries as of 18 Aug 2023. Jeanne M Morris has collaborated with a combinined 3307 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
82
Last Inspection Date:
18 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Sweden, Canada, Dominican Republic
Co-Investigator(s):
Adam J Taylor, Adrianna G Vargo, Alicia M Mozzachio, Allen F Hall, Amanda Dinaro, Amanda S Zorn, Ana L Kewes, Andrew A Leboeuf, Ann Marie Montemurro, Ann Marie Schofield, Anna Flynn, Anthony F Lorenzo, Anthony J Ladner, Ashley L Reiber, Barry Cherney, PhD, Brentley S Collins, Brian D Nicholson, Bruce H Mccullough, Burnell M Henry, Carl A Huffman, III, Carrie Ann Plucinski, CDR Sean T Creighton, Chad E Schmear, Cheryl A Kmiec, Chiang Syin, PhD, Christina A Miller, Christina V Santos, Christopher B Harding, Christopher D Leach, Claire M Minden, Clotia Cabbey Mensah, Colleen E Burke, Daniel C Kearns, Daniel Kearns, Darrell E Luedtke, David J Gasparovich, David Perkins, Deborah M Trout, Debra Boyd Seale, Debra I Love, Debra L Boyd Seale, Decarlos A Gomez, Denarvis C Mendenhall, Denise L Burosh, Dr. Andrew Shroke, Dr. Gang Wang, PhD, Dr. Guang Gao, PhD, Eliezar Ramos, Elliot P Cowam, PhD, Eric A Breselow, Eric M Mueller, PharmD, Eric S Pittman, Eric T Huebler, Esther A Ofori, Gene D Arcy, Gregory Price, Gregory R Dill, Gregory W Smith, Harperd, Helen B Ricalde, Humera Khan, Humera T Khan, Ismael Olvera, IV, Jacqueline Mdiaz Albertini, James W Plucinski, Jan B Welch, Jan Welch, Janae D Price, Jason F Chancey, Jeanne J Chiu, Jeanne J Thai, Jennifer Alongie Vollom, Jennifer C Adams, Jennifer C Johnson, Jennifer L Schmidt, Jesse A Vazquez, Jesse P Romenesko, Jessica L Burley, Joan A Loreng, John A Iwen, John M Seale, Joseph A Morkunas, Julie D Bringger, Karen Emasley Joseph, Karen Emaslwey Joseph, Kathleen A Schelble, Kathleen B Swat, Kathleen S Tormey, Kimberly Lewandowski Walker, Kujtim Sadiku, Kyran R Gibson, Lagurta M Mayher, Lakisha M Williams, Laura Fontan, MS, Lauren A Crivellone, Laurie A Haxel, LCDR Debra Emerson, LCDR Mark A Jimenez, RN, LCDR Michael H Tollon, LCDR Randall L Morris, Leeterry Moore, Lequita M Mayhew, Lewis K Antwi, Linda F Murphy, Lisa Hayka, Lisa Hornback, Lisa M Bellows, Lisa M Feola, Lorelei S Jarrell, Maksim A Levenchuk, Marcia A Worley, Margaret L Bolte, Margaret M Annes, Margaret Mtorres Vazquez, Margaret Torres Vazquez, Marie A Fadden, Mark E Frank, Martha T Olone, Matthew J Sienko, Maureen C Melvin, Melissa D Kalik, Melissa J Holz, Michael D Robinson, Michele L Glendenning, Michelle J Glembin, Mihaly S Ligmond, Nicholas F Lyons, Nicholas P Diorio, Nicholas Z Lu, Nicole J Clausen, Nicole K Trudel, Nicole S Williams, Norman K Starks, Norman Wong, Omotunde O Osunsanmi, Paola S Barnett, Patricia A Mcilroy, Paul M Chefor, Paula A Trost, Phung Thien Nguyen, Prabhu P Raju, Rachel T Evans, Rafael Padilla, Ralph A Erickson, Rebecca K Olin, Richard Heath Coats, Richard T Riggie, Robert C Steyert, Robert L Stevenson, Roberta W Cunningham, Rona Leblanc, PhD, Rose M Ashley, Russ R Rivy, Russell K Riley, Samuel W Labinjo, Sarah A Palmer, Sarah B Tanksley, Sarah E Mcmullen, Sarah L Roman, Scott K Zika, Sean R Bryd, Sharon L Matson, Sherea L Dillon, Simone E Pitts, Sonya L Karsik, State Agency, Stephanie A Wright, Stephen D Brown, Stephen D Eich, Sullan, Susan A Zullo, PhD, Susan M Jackson, Susan M North, Susan P Bruederle, Susan W Ciani, Tamara Brey, Tara C Alcazar, Teresa Jimenez, That Q Dang, Thomas J Arista, Thomas W Nojek, Thunder N Dunkijacobs, Todd M Stankewicz, Unnee Ranjan, Uruaku A Obasi, William R Weissinger, Yonggang Wang, PhD

Jeanne M Morris's Documents

Publish Date Document Type Title
February, 2003 FDA 483 Vitalant - Form 483, 2003-02-05
April, 2002 EIR Baxter Healthcare Corporation - EIR, 2002-02-11
March, 2000 FDA 483 AbbVie Inc. - Form 483, 2000-03-22
May, 2000 EIR Das Gupta, Tapas K. - EIR, 2000-05-19
January, 2000 EIR Paller, Amy, M.D. - EIR, 2000-01-24
May, 2001 FDA 483 CSL Behring L.L.C. - Form 483, 2001-05-24
October, 2000 EIR Vitalant - EIR, 2000-10-13
October, 2000 FDA 483 Vitalant - Form 483, 2000-10-13
March, 2004 FDA 483 Baxter Healthcare Corporation - Form 483, 2004-03-02
May, 2001 EIR CSL Behring L.L.C. - EIR, 2001-05-24
August, 2002 FDA 483 Gift of Hope - Organ & Tissue Donor Network - Form 483, 2002-08-19
March, 2004 EIR Baxter Healthcare Corporation - EIR, 2004-02-13
November, 2003 EIR Abbott Laboratories - EIR, 2003-11-13
May, 2000 FDA 483 Response Das Gupta, Tapas K. - Form 483R, 2001-03-27
April, 2002 EIR Baxter Healthcare Corp Renal Div - EIR, 2002-04-04
August, 2002 EIR Gift of Hope - Organ & Tissue Donor Network - EIR, 2002-08-19
November, 2002 FDA 483 VVF ILLINOIS SERVICES LLC - Form 483, 2002-11-07
April, 2002 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2002-03-01
January, 2000 FDA 483 Coral Blood Services, Inc. Children's Memorial Hospital - Form 483, 2000-01-24
October, 2000 FDA 483 Response Vitalant - Form 483R, 2000-11-30
March, 2004 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2004-03-15
March, 2004 EIR Baxter Healthcare Corporation - EIR, 2004-03-02
March, 2000 FDA 483 Response AbbVie Inc. - Form 483R, 2000-04-06
March, 2000 EIR AbbVie Inc. - EIR, 2000-03-22
September, 2002 FDA 483 Hobart Laboratories, Inc - Form 483, 2002-09-16
January, 2002 FDA 483 Baxter Althin Medical AB - Form 483, 2002-01-17
February, 2003 EIR Vitalant - EIR, 2003-02-05
April, 2002 FDA 483 Baxter Healthcare Corporation - Form 483, 2002-02-11
September, 2002 EIR Hobart Laboratories, Inc - EIR, 2002-09-16
May, 2000 FDA 483 Das Gupta, Tapas K. - Form 483, 2000-05-19
April, 2002 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2002-04-12
July, 2000 EIR Loyola University Chicago Health Sciences Campus IRB - EIR, 2000-07-31

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more